BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 103 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $429,282 | +0.6% | 60,633 | 0.0% | 0.03% | +3.8% |
| Q2 2023 | $426,857 | -15.6% | 60,633 | 0.0% | 0.03% | -18.8% |
| Q1 2023 | $505,680 | -27.4% | 60,633 | 0.0% | 0.03% | -31.9% |
| Q4 2022 | $696,067 | -8.9% | 60,633 | 0.0% | 0.05% | -16.1% |
| Q3 2022 | $764,000 | +19.2% | 60,633 | 0.0% | 0.06% | +24.4% |
| Q2 2022 | $641,000 | -35.0% | 60,633 | 0.0% | 0.04% | -21.1% |
| Q1 2022 | $986,000 | +17.4% | 60,633 | 0.0% | 0.06% | +11.8% |
| Q4 2021 | $840,000 | +94.9% | 60,633 | +102.1% | 0.05% | +75.9% |
| Q3 2021 | $431,000 | +36.4% | 30,000 | +50.0% | 0.03% | +38.1% |
| Q2 2021 | $316,000 | +55.7% | 20,000 | 0.0% | 0.02% | +31.2% |
| Q1 2021 | $203,000 | -17.8% | 20,000 | -39.7% | 0.02% | -20.0% |
| Q4 2020 | $247,000 | +116.7% | 33,157 | 0.0% | 0.02% | +100.0% |
| Q3 2020 | $114,000 | +20.0% | 33,157 | +65.8% | 0.01% | +11.1% |
| Q2 2020 | $95,000 | +137.5% | 20,000 | 0.0% | 0.01% | +80.0% |
| Q1 2020 | $40,000 | -42.0% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q4 2019 | $69,000 | +21.1% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $57,000 | -25.0% | 20,000 | 0.0% | 0.01% | -25.0% |
| Q2 2019 | $76,000 | -53.4% | 20,000 | 0.0% | 0.01% | -55.6% |
| Q1 2019 | $163,000 | +1.2% | 20,000 | 0.0% | 0.02% | -18.2% |
| Q4 2018 | $161,000 | +5.9% | 20,000 | 0.0% | 0.02% | -47.6% |
| Q3 2018 | $152,000 | +33.3% | 20,000 | 0.0% | 0.04% | +20.0% |
| Q2 2018 | $114,000 | +20.0% | 20,000 | 0.0% | 0.04% | +9.4% |
| Q1 2018 | $95,000 | -3.1% | 20,000 | 0.0% | 0.03% | -3.0% |
| Q4 2017 | $98,000 | -6.7% | 20,000 | 0.0% | 0.03% | -13.2% |
| Q3 2017 | $105,000 | -5.4% | 20,000 | 0.0% | 0.04% | -13.6% |
| Q2 2017 | $111,000 | -33.9% | 20,000 | 0.0% | 0.04% | -37.1% |
| Q1 2017 | $168,000 | +32.3% | 20,000 | 0.0% | 0.07% | +22.8% |
| Q4 2016 | $127,000 | +44.3% | 20,000 | 0.0% | 0.06% | +54.1% |
| Q3 2016 | $88,000 | +54.4% | 20,000 | 0.0% | 0.04% | +48.0% |
| Q2 2016 | $57,000 | 0.0% | 20,000 | 0.0% | 0.02% | -16.7% |
| Q1 2016 | $57,000 | -72.3% | 20,000 | 0.0% | 0.03% | -72.0% |
| Q4 2015 | $206,000 | -9.6% | 20,000 | 0.0% | 0.11% | -7.8% |
| Q3 2015 | $228,000 | -23.7% | 20,000 | 0.0% | 0.12% | -13.4% |
| Q2 2015 | $299,000 | +65.2% | 20,000 | 0.0% | 0.13% | +63.4% |
| Q1 2015 | $181,000 | +49.6% | 20,000 | +100.0% | 0.08% | +28.1% |
| Q4 2014 | $121,000 | +23.5% | 10,000 | 0.0% | 0.06% | +18.5% |
| Q3 2014 | $98,000 | – | 10,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |